Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature

Pulmonary toxicity from immune checkpoint inhibitor therapy is typically a severe and potentially fatal complication, but these observations are driven by the most common toxicity, pneumonitis. Rarer pulmonary immune related adverse events, like airway disease and sarcoidosis, may have a more benign...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, Felipe, Torre-Sada, Luis F., Mott, Frank E., Kim, Sang T., Nurieva, Roza, Shannon, Vickie R., Faiz, Saadia A., Casal, Roberto F., Altan, Mehmet, Lin, Julie, Sheshadri, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195014/
https://www.ncbi.nlm.nih.gov/pubmed/37214206
http://dx.doi.org/10.36401/JIPO-22-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195014/
https://www.ncbi.nlm.nih.gov/pubmed/37214206
http://dx.doi.org/10.36401/JIPO-22-30

Ejemplares similares